Innoviva Stock Today
| INVA Stock | USD 14.93 0.02 0.13% |
Performance0 of 100
| Odds Of DistressLess than 3
|
Innoviva is trading at 14.93 as of the 23rd of April 2024, a -0.13 percent decrease since the beginning of the trading day. The stock's open price was 14.95. Innoviva has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Innoviva are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of March 2024 and ending today, the 23rd of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 5th of October 2004 | Category Healthcare | Classification Health Care |
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California. Innoviva operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 63.23 M outstanding shares of which 11.33 M shares are currently shorted by private and institutional investors with about 13.53 trading days to cover. More on Innoviva
Moving against Innoviva Stock
| 0.81 | OPT | Opthea | PairCorr |
| 0.79 | LLY | Eli Lilly Earnings Call This Week | PairCorr |
| 0.78 | ERNA | Eterna Therapeutics | PairCorr |
| 0.75 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
| 0.73 | A | Agilent Technologies Earnings Call This Week | PairCorr |
| 0.68 | CRL | Charles River Labora Financial Report 9th of May 2024 | PairCorr |
| 0.67 | IQV | IQVIA Holdings Financial Report 25th of April 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores
Innoviva Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Innoviva's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Innoviva or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO and President and Director | Michael Aguiar | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Thematic Ideas | (View all Themes) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, SP Small-Cap 600, NASDAQ Biotechnology, NASDAQ Composite, NASDAQ Health Care, Aggressive Defence, Tech Growth, Health Care, Pharmaceuticals, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering Innoviva report their recommendations after researching Innoviva's financial statements, talking to executives and customers, or listening in on Innoviva's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Innoviva. The Innoviva consensus assessment is calculated by taking the average forecast from all of the analysts covering Innoviva. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from Innoviva's financial statements, Innoviva is doing better financially then in previous quarter. It has a moderate probability of reporting better financial numbers in May. Financial strength of Innoviva is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Innoviva's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Innoviva's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Innoviva's financial leverage. It provides some insight into what part of Innoviva's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Innoviva (INVA) is traded on NASDAQ Exchange in USA. It is located in 1350 Old Bayshore Highway, Burlingame, CA, United States, 94010 and employs 112 people. Innoviva is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 945.25 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Innoviva's market, we take the total number of its shares issued and multiply it by Innoviva's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Innoviva conducts business under Pharmaceuticals sector and is part of Health Care industry. The entity has 63.23 M outstanding shares of which 11.33 M shares are currently shorted by private and institutional investors with about 13.53 trading days to cover.
Innoviva currently holds about 283.58 M in cash with 141.06 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.07.
Check Innoviva Probability Of Bankruptcy
Ownership AllocationInnoviva secures a total of 63.23 Million outstanding shares. The majority of Innoviva outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Innoviva to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Innoviva. Please pay attention to any change in the institutional holdings of Innoviva as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check Innoviva Ownership Details
Innoviva Stock Price Odds Analysis
What are Innoviva's target price odds to finish over the current price? Depending on a normal probability distribution, the odds of Innoviva jumping above the current price in 90 days from now is about 74.59%. The Innoviva probability density function shows the probability of Innoviva stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Innoviva has a beta of 0.8979. This usually indicates Innoviva market returns are sensitive to returns on the market. As the market goes up or down, Innoviva is expected to follow. Additionally, innoviva has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Innoviva to move above the current price in 90 days from now is about 74.59 (This Innoviva probability density function shows the probability of Innoviva Stock to fall within a particular range of prices over 90 days) .
Innoviva Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Innoviva that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Innoviva's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Innoviva's value.| Instituion | Recorded On | Shares | |
| Pacer Advisors, Inc. | 2023-12-31 | 1.7 M | |
| Geode Capital Management, Llc | 2023-12-31 | 1.3 M | |
| Amvescap Plc. | 2023-12-31 | 1.2 M | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 933.3 K | |
| Assenagon Asset Management Sa | 2023-12-31 | 810.2 K | |
| Bank Of America Corp | 2023-12-31 | 797.1 K | |
| Northern Trust Corp | 2023-12-31 | 721.2 K | |
| Deutsche Bank Ag | 2023-12-31 | 719.5 K | |
| D. E. Shaw & Co Lp | 2023-09-30 | 710.6 K | |
| Blackrock Inc | 2023-12-31 | 10.4 M | |
| Sarissa Capital Management Lp | 2023-09-30 | 7.3 M |
Innoviva Historical Income Statement
Innoviva Income Statement is one of the three primary financial statements used for reporting Innoviva's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Innoviva revenue and expense. Innoviva Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Innoviva's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 258.2 M, whereas Interest Expense is forecasted to decline to about 15.6 M. View More FundamentalsInnoviva Stock Against Markets
Picking the right benchmark for Innoviva stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Innoviva stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Innoviva is critical whether you are bullish or bearish towards Innoviva at a given time. Please also check how Innoviva's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Innoviva without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Innoviva Corporate Directors
Innoviva corporate directors refer to members of an Innoviva board of directors. The board of directors generally takes responsibility for the Innoviva's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Innoviva's board members must vote for the resolution. The Innoviva board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| George Bickerstaff | Independent Director | Profile | |
| Barbara Duncan | Independent Director | Profile | |
| Paul Pepe | Independent Director | Profile | |
| Patrick LePore | Independent Director | Profile |
How to buy Innoviva Stock?
Before investing in Innoviva, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Innoviva. To buy Innoviva stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Innoviva. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Innoviva stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Innoviva stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Innoviva stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Innoviva, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Innoviva Stock please use our How to Invest in Innoviva guide.
Already Invested in Innoviva?
The danger of trading Innoviva is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Innoviva is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Innoviva. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Innoviva is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Innoviva offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Innoviva's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Innoviva Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Innoviva Stock: Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innoviva. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real. For information on how to trade Innoviva Stock refer to our How to Trade Innoviva Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Innoviva Stock analysis
When running Innoviva's price analysis, check to measure Innoviva's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innoviva is operating at the current time. Most of Innoviva's value examination focuses on studying past and present price action to predict the probability of Innoviva's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innoviva's price. Additionally, you may evaluate how the addition of Innoviva to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Stocks Directory Find actively traded stocks across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |
Is Innoviva's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innoviva. If investors know Innoviva will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innoviva listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Earnings Share 2.2 | Revenue Per Share 4.745 | Quarterly Revenue Growth 0.305 | Return On Assets 0.0712 |
The market value of Innoviva is measured differently than its book value, which is the value of Innoviva that is recorded on the company's balance sheet. Investors also form their own opinion of Innoviva's value that differs from its market value or its book value, called intrinsic value, which is Innoviva's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innoviva's market value can be influenced by many factors that don't directly affect Innoviva's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innoviva's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innoviva is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innoviva's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.